Objective To study the effect of cervical screening on incidence of cervical cancer as a function
of age with particular focus on women screened under the age of 25. Design Population …

Background Human papillomavirus (HPV) immunisation with a bivalent vaccine (Cervarix)
was introduced in England, UK, in Sept 1, 2008: routine vaccination was offered to girls aged …

Background: It is well established that screening can prevent cervical cancer, but the
magnitude of the impact of regular screening on cervical cancer mortality is unknown. Methods: …

Screening has had a major impact on cervical cancer in many countries. Although there can
be no doubt about its effectiveness in preventing squamous‐cell carcinoma, there is little …

Background There is little consensus, and minimal evidence, regarding the age at which to
stop cervical screening. We studied the association between screening at age 50–64 y and …

RESEARCH Page 1 Risk of preterm birth after treatment for cervical intraepithelial neoplasia
among women attending colposcopy in England: retrospective-prospective cohort study …

Objective To determine the association between depth of excision of cervical intraepithelial
neoplasia and risk of preterm birth. Design Case-control study nested in record linkage …

While the incidence of squamous carcinoma of the cervix has declined in countries with
organised screening, adenocarcinoma has become more common. Cervical screening by …

Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Testing for E6/E7 mRNA in cells infected with high-risk (HR) human papillomavirus (HPV)
might improve the specificity of HPV testing for the identification of cervical precancerous …